...
首页> 外文期刊>Hellenic Journal of Cardiology >Peritoneal dialysis as a therapeutic solution in elderly patients with cardiorenal syndrome and heart failure: A case-series report
【24h】

Peritoneal dialysis as a therapeutic solution in elderly patients with cardiorenal syndrome and heart failure: A case-series report

机译:腹膜透析作为老年心肺综合征和心力衰竭患者治疗溶液:案例系列报告

获取原文
           

摘要

The aim of this work was to evaluate the impact of peritoneal dialysis (PD) on venous congestion, right ventricle function, pulmonary artery systolic pressure (PASP) and clinical functional status in elderly patients with cardiorenal syndrome (CRS) and chronic heart failure (HF). A case series of 21 (17 males, age 70±11 years) consecutive patients with diuretic-resistance HF and right ventricular dysfunction (median renal failure duration 60 months, range 13-287 months, mean ejection fraction 36±11%) having been engaged in PD; 76% of the patients were under Automated Peritoneal Dialysis (APD), whereas the rest were under Continuous Ambulatory PD (CAPD). Patients' PASP and central venous pressure (CVP) - through compression sonography - and body weight were evaluated before initiating PD program, at 6 months and at 12 months. During the follow-up period, the mortality rate was 8 deaths out of 21 patients (38%) A significant reduction by 29.9% in PASP levels (p=0.013) and by 42% in CVP levels (p0.001), and in right ventricular function assessed by tricuspid annulus tissue doppler velocity (p= 0.04) was observed; whereas patients weight increased by 3.7% (p=0.001). New York Heart Association class improved in 12 patients; whereas, in the rest patients remained constant (p=0.046). In 8 patients complications were reported (mainly presence of staphylococcus. aureus). In conclusion, PD seems to confer a substantial benefit in clinical status, in line with improvement in venous congestion and right ventricle systolic pressure among elderly HF patients with CRS. Copyright ? 2019 Hellenic Society of Cardiology. Published by Elsevier B.V. All rights reserved.
机译:这项工作的目的是评估腹膜透析(Pd)对静脉充血,右心室功能,肺动脉收缩压(PASP)和患有心肺心血综合征(CRS)和慢性心力衰竭患者的临床功能状态的影响(HF )。一种案例系列21(17名男性,70岁±11年)连续利尿耐药性HF和右心室功能障碍(中位肾功能衰竭持续时间60个月,范围13-287个月,平均喷射分数36±11%)从事PD; 76%的患者在自动腹膜透析(APD)下,而其余部分在连续的动态Pd(CAPD)下。在6个月和12个月内,在启动PD程序之前评估患者的皮卡和中心静脉压(CVP) - 通过压缩超声和体重和体重。在随访期间,21例患者中的死亡率为8例(38%)在PASP水平下显着减少29.9%(P = 0.013),CVP水平的42%(P <0.001),以及观察到由Tricuspid环形组织多普勒速度评估的右心室功能(P = 0.04);虽然患者重量增加3.7%(p = 0.001)。纽约心脏协会阶级12名患者改善;虽然,在静止患者中持续持续(p = 0.046)。在8名患者中,报告了并发症(主要存在葡萄球菌。金黄色葡萄球菌)。总之,PD似乎在临床状态下赋予了大量的益处,符合CRS的老年人HF患者的静脉充血和右心室收缩压的改善。版权? 2019年希腊病学会。由elsevier b.v出版。保留所有权利。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号